We surmised understanding AIS would uncover insights into potential tumor-suppressive and resistance mechanisms and provide new avenues for future therapeutic exploitation targeting PI3K/AKT/mTORC1-driven cancers. This evidence concerns the gene PIK3CA and neoplasm.